Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.
about
Responder analyses in randomised controlled trials for chronic low back pain: an overview of currently used methodsPragmatic Implementation of a Stratified Primary Care Model for Low Back Pain Management in Outpatient Physical Therapy Settings: Two-Phase, Sequential Preliminary Study.Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data.Improving the power of clinical trials of rheumatoid arthritis by using data on continuous scales when analysing response rates: an application of the augmented binary methodResponder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practiceA comparison of change in the 0-10 numeric rating scale to a pain relief scale and global medication performance scale in a short-term clinical trial of breakthrough pain intensity.Interpreting effect sizes and clinical relevance of pharmacological interventions for fibromyalgia.Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ERAn open-label pilot study of pulsed electromagnetic field therapy in the treatment of failed back surgery syndrome pain.Interpreting patient-reported outcome results: US FDA guidance and emerging methods.The effect of OPC Factor on energy levels in healthy adults ages 45-65: a phase IIb randomized controlled trialA randomized controlled trial of exercise versus wait-list in chronic tennis elbow (lateral epicondylosis).Survival functions for defining a clinical management Lost To Follow-Up (LTFU) cut-off in Antiretroviral Therapy (ART) program in Zomba, Malawi.Minimal important improvement thresholds for the six-minute walk test in a knee arthroplasty cohort: triangulation of anchor- and distribution-based methods.Medications development to treat alcohol dependence: a vision for the next decade.Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot studyNumbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scoresIntegrating acupuncture with exercise-based physical therapy for knee osteoarthritis: a randomized controlled trialThe Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.A pilot trial of intravenous pamidronate for chronic low back pain.Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trialsReporting outcomes of back pain trials: a modified Delphi study.Interpretation of patient-reported outcomes.Treating low back pain with combined cerebral and peripheral electrical stimulation: A randomized, double-blind, factorial clinical trial.Clinically relevant pain relief with an ibuprofen-releasing foam dressing: results from a randomized, controlled, double-blind clinical trial in exuding, painful venous leg ulcers.Trimmed means for symptom trials with dropouts.Clinical Experience With Desvenlafaxine in Treatment of Patients With Fibromyalgia Syndrome.A taxonomy of estimands for regulatory clinical trials with discontinuations.A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain.Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.Applying area-under-the-curve analysis to enhance interpretation of response profiles: an application to sleep quality scores in patients with fibromyalgia.Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective.Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol.A randomized controlled trial of eccentric vs. concentric graded exercise in chronic tennis elbow (lateral elbow tendinopathy).Intravenous Oxycodone versus Intravenous Morphine in Cancer Pain: A Randomized, Open-Label, Parallel-Group, Active-Control Study.
P2860
Q26858781-E6D3F5FE-6DA9-4D62-B022-849B79BE574AQ27334905-C30BABE9-DCCD-4E77-9E2B-4E283BB5686FQ31108529-9FD28A53-B646-4F69-BAA7-BFFDF187898CQ31110280-4A4A1F5E-040B-4775-B853-A3AC3C54D78AQ33566361-BCBCC130-40FC-4743-9B52-D49D32799079Q33908141-2E0EADD8-22FB-4EF4-B509-48BE23BCE218Q33938142-3D57B637-6F41-474D-8C25-1E0AC6CD7EDCQ34693256-DCEAE0B1-9DC9-47E9-8BB0-E8EEDA2836BCQ35049327-45F6CAD5-7923-480A-A0FF-80A70480B658Q35075349-7EA53B45-B4C6-4F8E-8F9F-3278DB48AFDCQ35157466-5742125A-5F45-4E4B-B968-4F16050B9737Q35514476-BFFD050D-0F00-4680-BF8B-5DD882646AB8Q36010200-C9836E47-2E00-426B-A5D1-D09C54DE5FC1Q36131812-7086C69A-3AAF-4051-B3A5-3A5C3BD1F3A5Q36357552-CC44C381-6E81-4DB3-94CE-7030E3EA2820Q36585607-C26B51AC-4297-4F72-AB38-974CBF7756EDQ36757015-DE45FC81-4E41-412B-AA64-5FDF2C6E1F5EQ37195089-E5038C81-07F5-44FF-B584-6AABC0933418Q37251244-AC6AF711-F98A-4D91-9C5F-F8DECC512D0CQ37626310-72C31871-8D5D-46F8-92AB-5635C647BC8FQ37662935-EB614365-EF89-47F6-8E3E-610DE568D03FQ37877390-C3611027-B516-4B87-8278-DB78BC7DA77DQ38083263-1951A224-74F2-4695-B9DD-B211D4EB490BQ39156524-950CC010-73F3-44DB-AD14-83E5A5E21E4FQ39239208-20D91F8E-3CA5-4D35-A83A-FE368DFBD2D6Q39491555-235B1139-9C7C-4071-A33B-9ED46E8CEDE0Q39800410-E9458D57-0D74-4084-86AC-F0C008627473Q40201276-F846DC09-E320-4232-885C-AD9FC3387824Q40797006-1698A06D-73A0-49A7-A9F2-35BB57AA7BCAQ42950103-C0507263-F939-42B2-93D3-32AA88DBB28AQ43728541-60DDCFD6-277D-43FE-917E-5E5A40250234Q44850061-8A87372D-1E96-4FC0-B271-2CB20D0CFA16Q47869113-ECBBD73B-F73F-45A2-8970-668BBAF4A563Q48519366-B3F0F7D6-DE60-49C5-A526-328729070032Q53126488-93BD8255-6524-4350-8148-AEB834BC91D5
P2860
Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Use of the cumulative proporti ...... rial data more understandable.
@ast
Use of the cumulative proporti ...... rial data more understandable.
@en
type
label
Use of the cumulative proporti ...... rial data more understandable.
@ast
Use of the cumulative proporti ...... rial data more understandable.
@en
prefLabel
Use of the cumulative proporti ...... rial data more understandable.
@ast
Use of the cumulative proporti ...... rial data more understandable.
@en
P2093
P1476
Use of the cumulative proporti ...... rial data more understandable.
@en
P2093
John T Farrar
Mitchell B Max
Robert H Dworkin
P304
P356
10.1016/J.JPAINSYMMAN.2005.08.018
P577
2006-04-01T00:00:00Z